Phase II MMRC trial of extended treatment with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) plus autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. 8510
Main Authors Zimmerman, Todd M., Griffith, Kent A., Jasielec, Jagoda, Rosenbaum, Cara Ann, McDonnell, Kathryn, Waite-Marin, Jessica, Berdeja, Jesus G., Raje, Noopur S., Reece, Donna Ellen, Vij, Ravi, Alonge, Mattina, Rosebeck, Shaun, Gurbuxani, Sandeep, Faham, Malek, Kong, Katherine A, Levy, Joan, Jakubowiak, Andrzej J.
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.8510